Answer FAQs About Insulin for Type 2 Diabetes
Insulin is in the spotlight...and you can help answer questions.
Medicare Part D now caps insulin co-pays at $35/month. And manufacturers are rolling out their own co-pay caps...and lower prices.
Plus Rezvoglar (insulin glargine-aglr) will soon join Semglee as a lower-cost interchangeable biosimilar for Lantus.